viratherapeutics.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
Meta Tags
| Title | Home · ViraTherapeutics |
| Description | Welcome to ViraTherapeutics develops a new class of immunotherapy drugs based on oncolytic (cancer-destroying) viruses. Our patent protected virus is designed to be |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 45.223.136.114 |
| Location | - |
Related Websites
| Site | Rank |
More to Explore
viratherapeutics.com Valuation
|
US$951,294
Last updated: 2023-05-08 05:37:57
viratherapeutics.com has Semrush global rank of 11,126,219. viratherapeutics.com has an estimated worth of US$ 951,294, based on its estimated Ads revenue. viratherapeutics.com receives approximately 109,765 unique visitors each day. Its web server is located in -, with IP address 45.223.136.114. According to SiteAdvisor, viratherapeutics.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$951,294 |
| Daily Ads Revenue | US$879 |
| Monthly Ads Revenue | US$26,344 |
| Yearly Ads Revenue | US$316,123 |
| Daily Unique Visitors | 7,318 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| viratherapeutics.com. | A | 7199 | IP: 45.223.136.114 |
| viratherapeutics.com. | A | 7199 | IP: 45.223.146.114 |
| viratherapeutics.com. | NS | 43200 | NS Record: ns2.observatoiredesmarques.fr. |
| viratherapeutics.com. | NS | 43200 | NS Record: obs.ns1.fr. |
| viratherapeutics.com. | NS | 43200 | NS Record: ns3.nameshield.net. |
| viratherapeutics.com. | MX | 43200 | MX Record: 10 mail3.boehringer-ingelheim.com. |
| viratherapeutics.com. | MX | 43200 | MX Record: 10 mail2.boehringer-ingelheim.com. |
| viratherapeutics.com. | MX | 43200 | MX Record: 10 mail1.boehringer-ingelheim.com. |
| viratherapeutics.com. | MX | 43200 | MX Record: 10 mail4.boehringer-ingelheim.com. |
| viratherapeutics.com. | TXT | 43200 | TXT Record: v=spf1 include:_spf.boehringer-ingelheim.com -all |
| viratherapeutics.com. | TXT | 43200 | TXT Record: globalsign-domain-verification=D37F6A40AC0580509698F577D095449E |
| viratherapeutics.com. | TXT | 43200 | TXT Record: MS=ms41523570 |
| viratherapeutics.com. | TXT | 43200 | TXT Record: ldn7fzlpw6wqv6zjsws20bdl7mb2p2tb |
| viratherapeutics.com. | TXT | 43200 | TXT Record: 5pwzbqcl2rfc8rwfqz3wl4315b2ybnjk |
| viratherapeutics.com. | TXT | 43200 | TXT Record: google-site-verification=pqk6hvMeoosCEb_Bwu8sc5RiCw8nxqU9TPAryBxz9k8 |
HtmlToTextCheckTime:2023-05-08 05:37:57
| Share this site Activate socialmedia plugins. Please read the privacy policy We make cancer immunotherapies more powerful Menu Home About ViraTherapeutics About us Our Team History Science & Business Outline Oncolytic Viruses VSV-GP Technology Scientific Publications News & Events Latest News Press Releases Events Careers Contact Welcome to ViraT herapeutics ViraT herapeutics develops a new class of immunotherapy drugs based on oncolytic (cancer-destroying) viruses. Our patent protected virus is designed to be safe for human beings and efficiently destroys cancer cells, while leaving normal tissues unharmed. ViraT herapeutics currently performs preclinical safety and efficacy studies for our modified Vesicular Stomatitis Virus (VSV-GP) and aims to conduct first clinical trials in cancer patients in the near future. We are committed to developing new treatments for people living with cancer and improving their quality of life. Watch our video: ViraTherapeutics Houskapreis 2013 Latest |
HTTP Headers
HTTP/1.1 301 Moved Permanently Location: https://viratherapeutics.com/ Content-Length: 0 Connection: close HTTP/2 308 location: https://www.viratherapeutics.com/ content-length: 0 strict-transport-security: max-age=31536000 HTTP/2 200 date: Fri, 29 Oct 2021 11:12:26 GMT server: Apache last-modified: Wed, 19 Aug 2020 12:26:22 GMT etag: "3222-5ad3a1c88f780" accept-ranges: bytes content-length: 12834 vary: Accept-Encoding,User-Agent content-type: text/html; charset=UTF-8 set-cookie: visid_incap_2638513=fDytm5n3TW+NMH+baXwZwxnXe2EAAAAAQUIPAAAAAAAL7r/q6patSrTGRQ+Dd3Wm; expires=Sat, 29 Oct 2022 08:26:26 GMT; HttpOnly; path=/; Domain=.viratherapeutics.com; Secure; SameSite=None set-cookie: incap_ses_114_2638513=HCJxRwM+RQkOztF83gKVARnXe2EAAAAAZw/onac+l/PlfcshAdw/nQ==; path=/; Domain=.viratherapeutics.com; Secure; SameSite=None strict-transport-security: max-age=31536000 x-cdn: Imperva x-iinfo: 5-60331907-60215414 pNNN RT(1635505945511 0) q(0 0 0 0) r(0 0) U5 |
viratherapeutics.com Whois Information
Domain Name: VIRATHERAPEUTICS.COM Registry Domain ID: 1735300984_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.nameshield.net Registrar URL: http://www.nameshield.net Updated Date: 2021-07-21T22:12:17Z Creation Date: 2012-07-23T13:30:19Z Registry Expiry Date: 2023-07-23T13:30:19Z Registrar: NAMESHIELD SAS Registrar IANA ID: 1251 Registrar Abuse Contact Email: abuse@nameshield.net Registrar Abuse Contact Phone: +33241182828 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS2.OBSERVATOIREDESMARQUES.FR Name Server: NS3.NAMESHIELD.NET Name Server: OBS.NS1.FR DNSSEC: unsigned >>> Last update of whois database: 2021-09-17T00:41:41Z <<< |